Zydus Lifesciences Ltd has received tentative approval from the US Food and Drug Administration for Dapagliflozin tablets in 5 mg and 10 mg strengths. The approval allows the company to market the product in the US once patent and exclusivity conditions are resolved.
Show moreStay Ahead – Explore Now! Geekay Wires Posts Strong Q3 FY26 Results: Income at ₹1.15 Billion, Net Profit ₹78.2 Million
Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.
Powered By Just Imagine
